Wilhelmi, T., Xu, X., Tan, X., Hulshoff, M. S., Maamari, S., Sossalla, S., . . . Zeisberg, E. M. (2020). Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1. Theranostics.

Wilhelmi, Tim, Xingbo Xu, Xiaoying Tan, Melanie S. Hulshoff, Sabine Maamari, Samuel Sossalla, Michael Zeisberg, and Elisabeth M. Zeisberg. "Serelaxin Alleviates Cardiac Fibrosis Through Inhibiting Endothelial-to-mesenchymal Transition Via RXFP1." Theranostics 2020.

Wilhelmi, Tim, et al. "Serelaxin Alleviates Cardiac Fibrosis Through Inhibiting Endothelial-to-mesenchymal Transition Via RXFP1." Theranostics 2020.